ライフサイエンスコーパス: acute myocarditis

1 naling is dispensable for the development of acute myocarditis.

2 ated genetic variants in 8% of patients with acute myocarditis.

3 n a population-based cohort of patients with acute myocarditis.

4 entify a novel microRNA for the diagnosis of acute myocarditis.

5 e (CMR) imaging is commonly used to diagnose acute myocarditis.

6 se Criteria is used to make the diagnosis of acute myocarditis.

7 lar magnetic resonance to detect and monitor acute myocarditis.

8 ng showed high accuracy for the diagnosis of acute myocarditis.

9 rence standard was the clinical evidence for acute myocarditis.

10 enhanced T1 shortening for the diagnosis of acute myocarditis.

11 R approaches in patients suspected of having acute myocarditis.

12 and global myocardium edema in patients with acute myocarditis.

13 s T. cruzi control and protection from fatal acute myocarditis.

14 acute from chronic MI and identification of acute myocarditis.

15 L-1beta, and IL-6 levels in the heart during acute myocarditis.

16 ting that IL-17A plays a minimal role during acute myocarditis.

17 min in cardiac myocytes, results in a lethal acute myocarditis.

18 rdiovirulent phenotype in a murine model for acute myocarditis.

19 ng over 12 months in patients with suspected acute myocarditis.

20 nt myocarditis, and 132 met the criteria for acute myocarditis.

21 lminant myocarditis compared with those with acute myocarditis.

22 ction at six months compared with those with acute myocarditis.

23 f interferon, may determine reovirus-induced acute myocarditis.

24 minant (fractional shortening 19 +/- 4%) and acute myocarditis (17 +/- 7%) had LV systolic dysfunctio

25 ompared with no improvement in patients with acute myocarditis (19 +/- 7%, p < 0.01 for interaction b

26 Eighteen patients with clinical diagnosis of acute myocarditis (25 years [23-38 years]; 78% males) we

27 compared with only 45 percent of those with acute myocarditis (95 percent confidence interval, 30 to

28 ction is one of the most prevalent causes of acute myocarditis, a disease that frequently is identifi

29 nfection is one of the most common causes of acute myocarditis, a serious and sometimes fatal disease

30 Coxsackievirus B3 (CVB3) is a major cause of acute myocarditis, a serious condition that is refractor

31 Acute myocarditis affects approximately 4 to 14 per 100

32 Acute myocarditis aggregates with DCM within families, w

33 tis (pAM), and expert consensus criteria for acute myocarditis (AM) and complicated myocarditis (CM).

34 Patients with acute myocarditis (AM) are at increased risk of adverse

35 e is observed not only in most patients with acute myocarditis (AM) but also in some oncology patient

36 Clinically, acute myocarditis (AM) implies a short time elapsed from

37 ) is widely used to confirm the diagnosis of acute myocarditis (AM) in the acute setting.

38 Acute myocarditis (AM) is a well-known cause of sudden d

39 enhancement (LGE) has not been clarified in acute myocarditis (AM) with preserved left ventricular (

40 ome sequencing of 42 unrelated children with acute myocarditis (AM), some with proven viral causes.

41 Background Hyperemia is a key component of acute myocarditis (AM).

42 mines the incidence and clinical outcomes of acute myocarditis among adults following mRNA vaccinatio

43 Totally 3176 patients with acute myocarditis and 31 760 controls were included (med

44 +/- 19 [SD]; 46 men) with clinically defined acute myocarditis and 42 healthy controls who underwent

45 Thirteen patients with acute myocarditis and a control group of seven healthy a

46 receiving alpha-MyHC-pulsed bmDCs developed acute myocarditis and accumulated interferon (IFN)-gamma

47 Concomitant acute myocarditis and acute coronary thrombosis is a rar

48 ations for the pathogenesis and treatment of acute myocarditis and allograft rejection.

49 Chagas disease, characterized by acute myocarditis and chronic cardiomyopathy, is caused

50 ackie-B-viruses (CVB) are frequent causes of acute myocarditis and dilated cardiomyopathy, but an eff

51 curacy to discriminate between patients with acute myocarditis and healthy controls was 86% for T2>52

52 t as BTR should be considered in the care of acute myocarditis and PPCM.

53 among unselected patients hospitalized with acute myocarditis and their first-degree relatives compa

54 ata from ITAMY (ITalian multicenter study on Acute MYocarditis) and evaluated CMR results from 386 pa

55 e myocardial infarction, acute pericarditis, acute myocarditis, and Ramsay-Hunt Syndrome.

56 Diagnosis, prognosis, and management of acute myocarditis are also discussed.

57 als of optimal therapeutic interventions for acute myocarditis are needed.

58 The risk of acute myocarditis associated with COVID-19 mRNA vaccinat

59 Occurrence of acute myocarditis by cardiovascular magnetic resonance i

60 cted with Brazil strain of T cruzi developed acute myocarditis by day 21 after infection, consisting

61 ulminant myocarditis is distinguishable from acute myocarditis by echocardiography.

62 role of viral RNA synthesis in induction of acute myocarditis by infecting primary cultures of cardi

63 Th2 responses reduce acute myocarditis by inhibiting Th1 responses via regula

64 cate that Th1-type immunity protects against acute myocarditis by reducing viral replication and prev

65 acute myocardial infarction associated with acute myocarditis caused by coronavirus 229E in a middle

66 mouse models with opposite susceptibility to acute myocarditis caused by the myotropic Colombiana str

67 lammatory microRNA-155 is upregulated during acute myocarditis, contributes to the adverse inflammato

68 Acute myocarditis, defined as a sudden inflammatory inju

69 ) had the highest diagnostic performance for acute myocarditis diagnosis (P < .05 against all other s

70 Patients with acute myocarditis did not have these features.

71 ammation in 2/17 participants diagnosed with acute myocarditis early after COVID-19 vaccination, but

72 ased cohort of 336 consecutive patients with acute myocarditis enrolled in London and Maastricht.

73 performed: first, to identify patients with acute myocarditis for the 3-month period between Februar

74 se Abs may contribute to the pathogenesis of acute myocarditis found in patients with KS.

75 e-associated myocarditis to 14 patients with acute myocarditis from other causes, we found that patie

76 inium enhancement, compared to patients with acute myocarditis from other causes.

77 el microRNA for distinguishing patients with acute myocarditis from those with myocardial infarction

78 /- 0.2 cm) at presentation, while those with acute myocarditis had increased diastolic dimensions (6.

79 s and severe hemodynamic compromise, whereas acute myocarditis has an indistinct presentation, less s

80 Acute myocarditis has been genetically linked to dilated

81 t in the human heart long after the signs of acute myocarditis have abated are still not completely u

82 tions regarding athletic participation after acute myocarditis have heightened the importance of earl

83 tients with COVID-19 vaccination- associated acute myocarditis have higher left ventricular ejection

84 ng findings were found to be consistent with acute myocarditis in 7 patients; 4 of whom had preceding

85 The abstract "Gedatolisib Associated Acute Myocarditis in a Patient with Breast Adenocarcinom

86 consistently and strongly upregulated during acute myocarditis in both humans and susceptible mice.

87 among the most commonly identified causes of acute myocarditis in children and adults and have been i

88 irus B3 (CVB3) is a principal viral cause of acute myocarditis in humans and has been implicated in t

89 erent reovirus reassortant viruses to induce acute myocarditis in mice correlates with cytopathogenic

90 Reovirus-induced acute myocarditis in mice serves as a model to investiga

91 vation, and reduced myocardial damage during acute myocarditis in mice.

92 a provide two insights into reovirus-induced acute myocarditis in mice.

93 enation for 147 patients with a diagnosis of acute myocarditis in the Extracorporeal Life Support Org

94 ear diagnostic and management guidelines for acute myocarditis in the pediatric population.

95 dition, we demonstrate that the induction of acute myocarditis involves the engagement of CD43 cytopl

96 Acute myocarditis is an inflammatory condition that may

97 Acute myocarditis is characterized by the rapid developm

98 Although acute myocarditis is observed in most patients with KS,

99 The short-term prognosis of acute myocarditis is usually good, but varies widely by

100 omatic and asymptomatic participants without acute myocarditis.Keywords: Myocarditis, Vaccination, CO

101 In particular, the relevance of acute myocarditis-like episodes for subsequent disease c

102 Twenty four patients with acute myocarditis (mean age +/- standard deviation, 34.7

103 localized granzyme B activity in hearts with acute myocarditis monitored by fluorescent molecular tom

104 Acute myocarditis must be considered in patients who pre

105 Patients with acute myocarditis (n=514) were identified from April 200

106 Acute myocarditis occurred less than 1 week after onset

107 ugh both T2 and T1 mapping reliably detected acute myocarditis, only T2 mapping discriminated between

108 y 2001 and November 2016 with a diagnosis of acute myocarditis (onset of symptoms <1 month) of whom 5

109 events; 0.3% (95% CI: 0.1%-0.5%) experienced acute myocarditis or pericarditis.

110 identify myocardial injury in patients with acute myocarditis or TTCM.

111 ican Heart Association criteria for probable acute myocarditis (pAM), and expert consensus criteria f

112 association of the mRNA-based vaccines with acute myocarditis, predominantly among male adolescents

113 roximately 82% to 95% of adult patients with acute myocarditis present with chest pain, while 19% to

114 In clinically suspected acute myocarditis, significant reductions in tissue inju

115 Functional Imaging, Feature-Tracking Strain, Acute Myocarditis Supplemental material is available for

116 s were significantly longer in patients with acute myocarditis than in control subjects (1185.3 msec

117 rotozoan parasite Trypanosoma cruzi leads to acute myocarditis that is accompanied by autoimmunity to

118 In contrast, acute myocarditis that is complicated by acute heart fai

119 hile viral RNA synthesis is a determinant of acute myocarditis, this is not due to generation of infe

120 esting should be considered in patients with acute myocarditis to help reassure the majority while im

121 The diagnosis of acute myocarditis typically requires either endomyocardi

122 The severity of acute myocarditis uniquely correlated with the proportio

123 Acute myocarditis was diagnosed according to the modifie

124 gnostic performance in the identification of acute myocarditis were calculated.

125 One hundred patients with suspected acute myocarditis were enrolled.

126 hophysiological mechanisms, and treatment of acute myocarditis were gained during the last years, no

127 bruary 1 and April 30, 2021, 7 patients with acute myocarditis were identified, of which 4 occurred w

128 Intense immunostaining was observed in acute myocarditis, whereas VP1 was detected in scattered

129 Group B enteroviruses are common causes of acute myocarditis, which can be a precursor of chronic m

130 y T1 shortening of 70% or greater identified acute myocarditis with 93% sensitivity, 100% specificity

131 ession in plasma obtained from patients with acute myocarditis with the expression in various control

132 n was different between myocardial layers in acute myocarditis, with midmyocardial GCS and subepicard